Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation.
Saved in:
| Title: | Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation. |
|---|---|
| Authors: | Jeng-Miller KW; Ophthalmic Consultants of Boston, Boston, MA, USA., Miller MA; Center for Systems Biology, Massachusetts General Hospital Research Institute, Boston, MA, USA.; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Heier JS; Ophthalmic Consultants of Boston, Boston, MA, USA. |
| Source: | The oncologist [Oncologist] 2024 May 03; Vol. 29 (5), pp. e616-e621. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38527005 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jeng-Miller+KW%22">Jeng-Miller KW</searchLink>; Ophthalmic Consultants of Boston, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Miller+MA%22">Miller MA</searchLink>; Center for Systems Biology, Massachusetts General Hospital Research Institute, Boston, MA, USA.; Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Heier+JS%22">Heier JS</searchLink>; Ophthalmic Consultants of Boston, Boston, MA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2024 May 03; Vol. 29 (5), pp. e616-e621. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38527005 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/oncolo/oyae014 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e616 Titles: – TitleFull: Ocular Effects of MEK Inhibitor Therapy: Literature Review, Clinical Presentation, and Best Practices for Mitigation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jeng-Miller KW – PersonEntity: Name: NameFull: Miller MA – PersonEntity: Name: NameFull: Heier JS IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 05 Text: 2024 May 03 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1549-490X Numbering: – Type: volume Value: 29 – Type: issue Value: 5 Titles: – TitleFull: The oncologist Type: main |
| ResultId | 1 |
